Global Prefilled Auto Injectors Market Estimated to Exceed US$ 3,616 Mn by 2022-end

Posted on 2018-05-31 by Mark Hub in Healthcare // 0 Comments

Fact.MR

Dublin 2, Ireland, 2018-May-31 — /EPR Network/ — Recently, a novel report developed using proven research methodologies at the headquarters of Fact. MR has identified various prominent factors and trends prompting market growth of prefilled auto injectors market. The study is titled as “Prefilled Auto Injectors Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022”, which deeply analyses the global market trends, with historical data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) during the mentioned forecast of 2017-2022. For the benefit of the readers, the report concludes with a special focus on the detailed profiles of the major vendors in the global prefilled auto injectors market.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=169

Growing preference for convenient injection of anticoagulants and the introduction of a spectrum of new biotech products is reflecting favorably on the global prefilled auto-injectors market. Over the next couple of years, use of prefilled auto-injectors is expected become widespread across the globe. The product has made self-inject procedures extremely convenient for patients, hence, gaining a significant amount of user trust. In addition, the next generation prefilled auto injectors are more advanced in terms of technology and design. Manufacturers are actively focusing on perfecting prefilled auto-injectors in order to facilitate their use in new therapeutic areas. Prefilled auto-injectors are essentially developed for more reliable and accurate injection. Factors as such are anticipated to further boost the global sales of prefilled auto-injectors. As per the latest report published by Fact.MR, the global prefilled auto injectors market is will surge at 15.3% CAGR during the forecast period (2017-2022).

Forecast Highlights on the Global Market for Prefilled Auto-Injectors

North America is projected to retain its predominant position in the global market for prefilled auto-injectors over 2022. In addition, the region’s prefilled auto-injectors market is anticipated to register an impressive CAGR during the projection period. This growth is mainly attributed to the expanding pool of patients who require drug administration on daily basis in the region. Factors such as low cost of prefilled auto-injectors and quick expansion of the healthcare industry are influencing Asia-Pacific excluding Japan (APEJ)’s prefilled auto injection market. The market in APEJ is expected to surge at little under 16% CAGR between 2017 and 2022. Currently, Europe accounts for over 10% share of the market in terms of revenue and is expected to exhibit lucrative opportunities for market players in the near future.

Browse Full Report with TOC- https://www.factmr.com/report/169/prefilled-auto-injectors-market

On the basis of indication, use of prefilled auto-injection is significantly high for treating anaphylaxis indication. Towards the end of the forecast period, nearly US$ 3,200 Mn worth prefilled auto-injectors is estimated to be used for treating anaphylaxis.

Online pharmacies are the largest distribution channel for prefilled auto injectors. In terms of revenue, online pharmacies currently account for around 33% share of the market. By the end of 2022, the online pharmacies distribution channel segment is estimated to reach a valuation of nearly US$ 1,500 Mn, reflecting a healthy CAGR.

North America Will Continue to Spearhead the Global Prefilled Auto-Injectors Market

In terms of revenue, North America is expected to dominate the global prefilled auto-injectors market over 2022. This is primarily owing to the rising number of patients who require drug administration on regular basis. Owing to the extreme convenience of administrating insulin, prefilled auto injectors are also gaining popularity among patients suffering from diabetes in the region. The prefilled auto injectors market in North America in expected to witness a strong growth over the forecast period. Meanwhile, robust development of the healthcare sector coupled with low cost of prefilled auto-injectors is proving to be instrumental for the growth of the market in Asia-Pacific excluding Japan (APEJ). Between 2017 and 2022, the region’s market is projected to increase at an impressive CAGR of 15.9%.

Based on indication, the anaphylaxis segment currently accounts for more than two-third revenue share of the market. The segment is estimated to reach a market valuation of over US$ 3,187 Mn towards the end of 2022, reflecting a strong CAGR. In addition, the segment is expected to growing at around US$ 320 Mn annually over the course of the assessment period.

Competition Tracking

Fact.MR’s report also profiled companies that are expected to remain active in the expansion of global prefilled auto injectors market through 2022, which include Becton, Dickinson and Company, Pfizer Inc., Mylan N.V., Antares Pharma, Inc., Amgen Inc., and Eli Lilly and Company.

Request Methodology of the Report- https://www.factmr.com/connectus/sample?flag=RM&rep_id=169

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Matched content

Editor’s pick